The Federal Trade Commission accused UnitedHealth's OptumRx, CVS Caremark, and Cigna's Express Scripts of pocketing over $7 ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...
The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the […] (Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...